WHO Webinar: Launch of new antimalarial drug resistance strategy for Africa

The WHO will launch a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa. This will take place during the webinar titled “Launch of new antimalarial drug resistance strategy for Africa“. The strategy is being released during World Antimicrobial Awareness Week, a global annual campaign to improve awareness of the growing threat of resistance to antibiotics and other medicines.

Artemisinin-based combination therapy (ACT) is the mainstay of malaria care in Africa, where the disease is by far the most prevalent. The treatment, introduced in the early 2000s, has played a major role in lowering the burden of malaria over the last 2 decades.

In recent years, however, WHO has been concerned by reports of emerging drug-resistant malaria in Africa. Parasites in some areas have developed partial resistance to artemisinin – the core compound of ACTs – and there are worrying signs that they may also be resistant to other drugs that are commonly partnered with artemisinin. Vigorous measures are needed to protect their efficacy.

Date: November 18, 2022

Time10:30 CET

Language: Discussions in English with simultaneous interpretation in French

If you’d like to attend, please register at this link.

Read more here.

SHARE

Upcoming opportunities